Kevin T Conroy
CIK 1306119 · President and CEO · last filed 2026-10-02
Kevin T Conroy is a President and CEO who has filed 161 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for ABT, was dated Oct 2, 2026. Across all open-market trades the lifetime net is −$170.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.3M across reported positions. 123 SEC filings were submitted jointly with EXACT SCIENCES CORP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EXAS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MADISON, WI 53719
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABT | Director | 81,230 | $110.46 | $8.97M | $0 | 4 | 2026-10-02 |
| ALGN | Director | 3,553 | $176.19 | $626.0K | $0 | 4 | 2026-05-22 |
| EXACT SCIENCES CORP (EXAS) Delisted | President and CEO | 0 | $104.91 | $0 | -$170.51M | 110 | 2026-03-23 |
| ADPT | Director | 22,968 | $30.66 | $704.1K | $0 | 4 | 2023-03-08 |
| Epizyme, Inc. (EPZM) Delisted | Director | 62,318 | $1.47 | $91.6K | $0 | 20 | 2022-07-05 |
| SomaLogic, Inc. (SLGCW) Delisted | Director | 25,000 | $0.09 | $2.1K | $0 | 1 | 2021-09-03 |
| THIRD WAVE TECHNOLOGIES INC /WI (TWTI) Delisted | President & CEO | 54,811 | — | — | $48.5K | 9 | 2008-05-09 |
Recent Filings
161 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-02 | ABT | Grant (A) | — | $0 | EDGAR |
| 2026-09-25 | ABT | Tax (F) | −52,507 | -$5.46M | EDGAR |
| 2026-07-01 | ABT | Grant (A) | — | $0 | EDGAR |
| 2026-05-22 | ALGN | Mixed | +1,745 | $0 | EDGAR |
| 2026-04-28 | ABT | Grant (A) | +2,286 | $0 | EDGAR |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −1,558,202 | $0 | EDGAR |
| 2026-03-03 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +36,090 | -$3.30M | EDGAR |
| 2026-02-27 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +6,985 | -$641.0K | EDGAR |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +378,382 | -$34.17M | EDGAR |
| 2025-05-22 | ALGN | Mixed | +1,148 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.